Protocol Single compound

GHRP-6

Growth hormone releasing peptide-6

Ghrelin-receptor agonist hexapeptide referenced in GH secretagogue research.

Laboratory reference · in vitro research data

Research vial sizes: 5 mg · 10 mg
Dosing data: Not listed — reference entry covers vial concentration only.
Storage: Powder: 2–8 °C, or −20 °C for longer storage. After mixing with BAC water: 2–8 °C, use within about 4 weeks.

Concentration per BAC-water volume; 10 units = 0.1 mL on a U-100 syringe.

Vial	BAC water	mg/mL	mg per 10 u
5 mg	1 mL	5	0.5
5 mg	2 mL	2.5	0.25
5 mg	3 mL	1.67	0.167
10 mg	1 mL	10	1
10 mg	2 mL	5	0.5
10 mg	3 mL	3.33	0.333

Draw to

—units

= — mL on a U-100 syringe

Syringe

U-100 · 100 units (1 mL)2 unit per line

GHRP-6 is a synthetic hexapeptide that stimulates GH release through the ghrelin (GH secretagogue) receptor and acts synergistically with GHRH.

As a diagnostic test, GH responses were lower in GH-deficient children than normal children, with considerable overlap; responses were almost completely blocked in pituitary stalk transection.
In rats, combined GHRH plus GHRP-6 was the most potent GH stimulus, showing synergy.

Not approved by the FDA or EMA for any indication; research-grade material is not a medicine.
Listed as prohibited in sport by the World Anti-Doping Agency.

Pombo M, et al. Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency. J Pediatr Endocrinol Metab. 1996;9 Suppl 3:333–338.1996Clinical reviewRead paper ↗
Diz-Chaves Y, et al. GH responses to GHRH and GHRP-6 in streptozotocin (STZ)-diabetic rats. Life Sci. 2003;73(26):3375–3385.2003-11Preclinical study (rat)Read paper ↗

Listings are provided for reference — always verify the latest third-party COA before purchasing.

See site

Featured supplier · third-party tested, COA published per batch

TBD

Placeholder — details coming soon

View productView COA

TBD

Placeholder — details coming soon

View productView COA